Brought to you by 
Oramed gets $5.2mm via private placement
25 Aug 2008
Executive Summary
Oramed Pharmaceuticals (oral insulin for diabetes) raised $5.2mm through the private placement of 8.67mm common shares priced at $0.60 each (a 5% discount) to twenty-nine accredited investors led by Montaur Capital Partners. Investors also received three-year warrants to buy another 4.26mm shares exercisable at $0.90 each.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
- Vaccines
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Oramed gets $5.2mm via private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice